(Q44572417)

4 December 2017

title

Structure-based, targeted deglycosylation of HIV-1 gp120 and effects on neutralization sensitivity and antibody recognition (English)

1 reference

4 December 2017

1 reference

8

Joseph Sodroski

1 reference

4 December 2017

4

Peter Kolchinsky

1 reference

4 December 2017

3

Peter D Kwong

1 reference

4 December 2017

9

Richard Wyatt

1 reference

4 December 2017

Markus Koch

1

1 reference

4 December 2017

Marie Pancera

2

1 reference

4 December 2017

Christoph Grundner

5

1 reference

4 December 2017

Liping Wang

6

1 reference

4 December 2017

Wayne A Hendrickson

7

1 reference

4 December 2017

language of work or name

English

0 references

publication date

1 September 2003

1 reference

4 December 2017

number of pages

14

1 reference

inferred from page(s)

published in

Virology

1 reference

4 December 2017

volume

313

1 reference

4 December 2017

issue

2

1 reference

4 December 2017

page(s)

387-400

1 reference

CC CKR5: a RANTES, MIP-1alpha, MIP-1beta receptor as a fusion cofactor for macrophage-tropic HIV-1

4 December 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0042-6822%2803%2900294-0

7 January 2021

An N-glycan within the human immunodeficiency virus type 1 gp120 V3 loop affects virus neutralization

1 reference

https://api.crossref.org/works/10.1016%2FS0042-6822%2803%2900294-0

7 January 2021

Human immunodeficiency virus (HIV) envelope binds to CXCR4 independently of CD4, and binding can be enhanced by interaction with soluble CD4 or by HIV envelope deglycosylation.

1 reference

https://api.crossref.org/works/10.1016%2FS0042-6822%2803%2900294-0

7 January 2021

Isolation of a T-Lymphotropic Retrovirus from a Patient at Risk for Acquired Immune Deficiency Syndrome (AIDS)

1 reference

https://api.crossref.org/works/10.1016%2FS0042-6822%2803%2900294-0

7 January 2021

Envelope proteins from clinical isolates of human immunodeficiency virus type 1 that are refractory to neutralization by soluble CD4 possess high affinity for the CD4 receptor

1 reference

https://api.crossref.org/works/10.1016%2FS0042-6822%2803%2900294-0

7 January 2021

An improved PCR-based method for site directed mutagenesis using megaprimers

1 reference

https://api.crossref.org/works/10.1016%2FS0042-6822%2803%2900294-0

7 January 2021

Efficient neutralization of primary isolates of HIV-1 by a recombinant human monoclonal antibody

1 reference

https://api.crossref.org/works/10.1016%2FS0042-6822%2803%2900294-0

7 January 2021

Core structure of gp41 from the HIV envelope glycoprotein

1 reference

https://api.crossref.org/works/10.1016%2FS0042-6822%2803%2900294-0

7 January 2021

HIV entry and its inhibition

1 reference

https://api.crossref.org/works/10.1016%2FS0042-6822%2803%2900294-0

7 January 2021

The beta-chemokine receptors CCR3 and CCR5 facilitate infection by primary HIV-1 isolates

1 reference

https://api.crossref.org/works/10.1016%2FS0042-6822%2803%2900294-0

7 January 2021

Change in coreceptor use correlates with disease progression in HIV-1--infected individuals

1 reference

https://api.crossref.org/works/10.1016%2FS0042-6822%2803%2900294-0

7 January 2021

Oligomeric structure of the human immunodeficiency virus type 1 envelope glycoprotein

1 reference

https://api.crossref.org/works/10.1016%2FS0042-6822%2803%2900294-0

7 January 2021

HIV-1 Entry Cofactor: Functional cDNA Cloning of a Seven-Transmembrane, G Protein-Coupled Receptor

1 reference

https://api.crossref.org/works/10.1016%2FS0042-6822%2803%2900294-0

7 January 2021

Detection of a fusion peptide sequence in the transmembrane protein of human immunodeficiency virus

1 reference

https://api.crossref.org/works/10.1016%2FS0042-6822%2803%2900294-0

7 January 2021

Frequent Detection and Isolation of Cytopathic Retroviruses (HTLV-III) from Patients with AIDS and at Risk for AIDS

1 reference

https://api.crossref.org/works/10.1016%2FS0042-6822%2803%2900294-0

7 January 2021

Sensitivity of HIV-1 to neutralization by antibodies against O-linked carbohydrate epitopes despite deletion of O-glycosylation signals in the V3 loop

1 reference

https://api.crossref.org/works/10.1016%2FS0042-6822%2803%2900294-0

7 January 2021

Loss of a single N-linked glycan allows CD4-independent human immunodeficiency virus type 1 infection by altering the position of the gp120 V1/V2 variable loops

1 reference

https://api.crossref.org/works/10.1016%2FS0042-6822%2803%2900294-0

7 January 2021

Increased neutralization sensitivity of CD4-independent human immunodeficiency virus variants

1 reference

https://api.crossref.org/works/10.1016%2FS0042-6822%2803%2900294-0

7 January 2021

Functional regions of the envelope glycoprotein of human immunodeficiency virus type 1

1 reference

https://api.crossref.org/works/10.1016%2FS0042-6822%2803%2900294-0

7 January 2021

HIV-1 evades antibody-mediated neutralization through conformational masking of receptor-binding sites

1 reference

https://api.crossref.org/works/10.1016%2FS0042-6822%2803%2900294-0

7 January 2021

Structures of HIV-1 gp120 envelope glycoproteins from laboratory-adapted and primary isolates

1 reference

https://api.crossref.org/works/10.1016%2FS0042-6822%2803%2900294-0

7 January 2021

Structure of an HIV gp120 envelope glycoprotein in complex with the CD4 receptor and a neutralizing human antibody

1 reference

https://api.crossref.org/works/10.1016%2FS0042-6822%2803%2900294-0

7 January 2021

Oligomeric modeling and electrostatic analysis of the gp120 envelope glycoprotein of human immunodeficiency virus

1 reference

https://api.crossref.org/works/10.1016%2FS0042-6822%2803%2900294-0

7 January 2021

The N-linked glycan of the V3 region of HIV-1 gp120 and CXCR4-dependent multiplication of a human immunodeficiency virus type 1 lymphocyte-tropic variant.

1 reference

https://api.crossref.org/works/10.1016%2FS0042-6822%2803%2900294-0

7 January 2021

The T4 gene encodes the AIDS virus receptor and is expressed in the immune system and the brain

1 reference

https://api.crossref.org/works/10.1016%2FS0042-6822%2803%2900294-0

7 January 2021

The N-terminal V3 loop glycan modulates the interaction of clade A and B human immunodeficiency virus type 1 envelopes with CD4 and chemokine receptors

1 reference

https://api.crossref.org/works/10.1016%2FS0042-6822%2803%2900294-0

7 January 2021

Energetics of the HIV gp120-CD4 binding reaction

1 reference

https://api.crossref.org/works/10.1016%2FS0042-6822%2803%2900294-0

7 January 2021

Host cell glycosylation of viral glycoproteins--a battlefield for host defence and viral resistance

1 reference

https://api.crossref.org/works/10.1016%2FS0042-6822%2803%2900294-0

7 January 2021

CD4 binding site antibodies inhibit human immunodeficiency virus gp120 envelope glycoprotein interaction with CCR5

1 reference

https://api.crossref.org/works/10.1016%2FS0042-6822%2803%2900294-0

7 January 2021

A role for carbohydrates in immune evasion in AIDS.

1 reference

https://api.crossref.org/works/10.1016%2FS0042-6822%2803%2900294-0

7 January 2021

A conserved HIV gp120 glycoprotein structure involved in chemokine receptor binding

1 reference

https://api.crossref.org/works/10.1016%2FS0042-6822%2803%2900294-0

7 January 2021

Conformational changes induced in the human immunodeficiency virus envelope glycoprotein by soluble CD4 binding

1 reference

https://api.crossref.org/works/10.1016%2FS0042-6822%2803%2900294-0

7 January 2021

Human immunodeficiency virus type 1 neutralization is determined by epitope exposure on the gp120 oligomer

1 reference

https://api.crossref.org/works/10.1016%2FS0042-6822%2803%2900294-0

7 January 2021

Rapid selection for an N-linked oligosaccharide by monoclonal antibodies directed against the V3 loop of human immunodeficiency virus type 1.

1 reference

https://api.crossref.org/works/10.1016%2FS0042-6822%2803%2900294-0

7 January 2021

Resistance to V3-directed neutralization caused by an N-linked oligosaccharide depends on the quaternary structure of the HIV-1 envelope oligomer

1 reference

https://api.crossref.org/works/10.1016%2FS0042-6822%2803%2900294-0

7 January 2021

Envelope glycoprotein determinants of neutralization resistance in a simian-human immunodeficiency virus (SHIV-HXBc2P 3.2) derived by passage in monkeys

1 reference

https://api.crossref.org/works/10.1016%2FS0042-6822%2803%2900294-0

7 January 2021

Effect of major deletions in the V1 and V2 loops of a macrophage-tropic HIV type 1 isolate on viral envelope structure, cell entry, and replication

1 reference

https://api.crossref.org/works/10.1016%2FS0042-6822%2803%2900294-0

7 January 2021

Atomic structure of a thermostable subdomain of HIV-1 gp41

1 reference

https://api.crossref.org/works/10.1016%2FS0042-6822%2803%2900294-0

7 January 2021

CCR5 coreceptor utilization involves a highly conserved arginine residue of HIV type 1 gp120.

1 reference

https://api.crossref.org/works/10.1016%2FS0042-6822%2803%2900294-0

7 January 2021

Antibody neutralization and escape by HIV-1

1 reference

https://api.crossref.org/works/10.1016%2FS0042-6822%2803%2900294-0

7 January 2021

Atomic structure of the ectodomain from HIV-1 gp41

1 reference

https://api.crossref.org/works/10.1016%2FS0042-6822%2803%2900294-0

7 January 2021

The antigenic structure of the HIV gp120 envelope glycoprotein

1 reference

https://api.crossref.org/works/10.1016%2FS0042-6822%2803%2900294-0

7 January 2021

The HIV-1 Envelope Glycoproteins: Fusogens, Antigens, and Immunogens

1 reference

https://api.crossref.org/works/10.1016%2FS0042-6822%2803%2900294-0

7 January 2021

Target cell-specific determinants of membrane fusion within the human immunodeficiency virus type 1 gp120 third variable region and gp41 amino terminus

1 reference

https://api.crossref.org/works/10.1016%2FS0042-6822%2803%2900294-0

7 January 2021

Selection for neutralization resistance of the simian/human immunodeficiency virus SHIVSF33A variant in vivo by virtue of sequence changes in the extracellular envelope glycoprotein that modify N-linked glycosylation.

1 reference

https://api.crossref.org/works/10.1016%2FS0042-6822%2803%2900294-0

7 January 2021

Neutralization of the human immunodeficiency virus type 1 primary isolate JR-FL by human monoclonal antibodies correlates with antibody binding to the oligomeric form of the envelope glycoprotein complex

1 reference

https://api.crossref.org/works/10.1016%2FS0042-6822%2803%2900294-0

7 January 2021

Rapid complementation assays measuring replicative potential of human immunodeficiency virus type 1 envelope glycoprotein mutants

1 reference

https://api.crossref.org/works/10.1016%2FS0042-6822%2803%2900294-0

7 January 2021

Direct measurement of soluble CD4 binding to human immunodeficiency virus type 1 virions: gp120 dissociation and its implications for virus-cell binding and fusion reactions and their neutralization by soluble CD4.

1 reference

https://api.crossref.org/works/10.1016%2FS0042-6822%2803%2900294-0

7 January 2021

Infectious properties of human immunodeficiency virus type 1 mutants with distinct affinities for the CD4 receptor

1 reference

https://api.crossref.org/works/10.1016%2FS0042-6822%2803%2900294-0

7 January 2021

Recognition properties of a panel of human recombinant Fab fragments to the CD4 binding site of gp120 that show differing abilities to neutralize human immunodeficiency virus type 1.

1 reference

https://api.crossref.org/works/10.1016%2FS0042-6822%2803%2900294-0

7 January 2021

An envelope modification that renders a primary, neutralization-resistant clade B human immunodeficiency virus type 1 isolate highly susceptible to neutralization by sera from other clades.

1 reference

https://api.crossref.org/works/10.1016%2FS0042-6822%2803%2900294-0

7 January 2021

Determinants of human immunodeficiency virus type 1 envelope glycoprotein activation by soluble CD4 and monoclonal antibodies

1 reference

https://api.crossref.org/works/10.1016%2FS0042-6822%2803%2900294-0

7 January 2021

Replicative function and neutralization sensitivity of envelope glycoproteins from primary and T-cell line-passaged human immunodeficiency virus type 1 isolates.

1 reference

https://api.crossref.org/works/10.1016%2FS0042-6822%2803%2900294-0

7 January 2021

10.1016/S0042-6822(03)00294-0

Identifiers

DOI

1 reference

4 December 2017

1 reference